openPR Logo
Press release

Atrial Septal Defect Market - Analysis and future growth opportunities by 2024

09-19-2017 01:27 PM CET | Health & Medicine

Press release from: Transparency Market Research - Healthcare IT

Atrial Septal Defect Market

Atrial Septal Defect Market

Global Atrial Septal Defect Market: Outlook

Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole is referred to as atrial septal defect. Huge and long-term atrial septal defects may lead to serious heart and lung damage. In some cases, extra blood volume can overfill the lungs and increases the blood pressure of the lungs, leading to pulmonary hypertension. Most of the congenital heart diseases are caused by certain genetic defects. The three most common types of atrial septal defects are ostium secundum atrial septal defect, ostium primum atrial septal defect and sinus venosus atrial septal. Various symptoms associated with atrial septal defect are as follows:

Difficulty in breathing (dyspnea)
Frequent respiratory infections
Swelling of legs and feet
Heart palpitations
Fatigue

Browse Full Report With ToC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=17066

Global Atrial Septal Defect Market: Key Segments

Based on diagnosis, the atrial septal defect market can be segmented as follows:

Electrocardiogram (ECG): ECG records the electrical activity of an individual and identifies heart problems
Chest X-ray: With the help of X-ray, condition of the heart and lungs are detected
Cardiac catheterization: In this test, a catheter is inserted into the heart via vein and any congenital heart defects can be diagnosed including amount of oxygen in the blood
Transesophageal echocardiography (TEE): The test provides an ultrasound image to provide a clearer image of the atria
Pulse oximetry: This test helps to detect whether oxygenated blood is mixing with deoxygenated blood, thereby confirming any type of heart defect
The medications which are used to reduce the signs and symptoms of atrial septal defect include beta blockers (Lopressor, Inderal), anticoagulants (Coumadin) and anti-platelet agents (aspirin). In some instances, surgery is also done to repair an atrial septal defect such as open-heart surgery and cardiac catheterization.

Fill the form for an exclusive sample of this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17066

Global Atrial Septal Defect Market: Regional Analysis

Based on geography, the atrial septal defect market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Out of these regions, North America holds a leading position in the market followed by Europe. The prime factors which are driving the growth of atrial septal defect market in these regions are high prevalence of genetic heart disorders, and growing awareness of the population regarding atrial septal defects. Moreover, technological advancement in the treatment of congenital heart diseases is also accentuating the growth of the market. Asia Pacific is the most lucrative market for the growth of atrial septal defect market. The advantageous factors which would propel the growth of the market in Asia Pacific are presence of large population base and emerging economies such as China, Malaysia, India and Vietnam. Furthermore, favorable reimbursement policies and increasing disposable income of the Asian population would further boost the growth of atrial septal defect market in the coming years.

About Us:-

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us:-

Transparency Market Research

90 State Street, Suite 700, Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Visit Blog: http://marketresearchreports2017.blogspot.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atrial Septal Defect Market - Analysis and future growth opportunities by 2024 here

News-ID: 726321 • Views:

More Releases from Transparency Market Research - Healthcare IT

Healthcare Information Systems Market - Increasing Government Funding for Healthcare Fuels North America’s Dominance
Healthcare Information Systems Market - Increasing Government Funding for Health …
The leading players in the global healthcare information systems market are Cerner Corporation, McKesson, and All Scripts. Collectively, these players held a share of 26% in the global market in 2015, states Transparency Market Research. The diversified portfolio of these companies is expected to help them maintain a lead in the coming years. Several companies in the global healthcare information systems market are expected to focus on increasing geographical presence
Healthcare Automation Market - Therapeutic Automation Remains Dominant Technology due to its Superiority
Healthcare Automation Market - Therapeutic Automation Remains Dominant Technolog …
Transparency Market Research (TMR) states that Siemens AG, General Electric Company, Swisslog Holding AG, and Koninklijke Philips N.V. are some of the leading companies in the global healthcare automation market. These players have consistently worked toward expansion of product portfolio and reinforcing business through innovation product development. In the coming years, to beat the competition, players are expected to plan for mergers and acquisitions to expand their horizons to newer
Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in Demand for Revenue Cycle Management
Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in …
McKesson Corporation, Allscripts, Cerner Corporation, and Optum Health, Inc. were the leading players in the global market for technology spending on revenue cycle management in 2015. These key companies show the common strengths in having built strong distribution channels and effective long-term partnerships. Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597 According to a research report released by Transparency Market Research, technology spending on revenue cycle management is expected to experience a buildup in competitive rivalries
Smart Healthcare Products Market: Integration of IoT and Big Data with Smart Healthcare Products to Boost the Market
Smart Healthcare Products Market: Integration of IoT and Big Data with Smart Hea …
The global smart healthcare products market is fragmented due to presence of high number of players who offer differentiated products. This allows players to focus on specific product types thus increasing their market presence. For instance, in 2014, Becton Dickinson & Company and Medtronic again were among leading vendors in smart syringes, Medtronic and Olympus Corporation led the smart pills sales, and Epic Systems Corporation and Allscripts Healthcare Solutions were

All 4 Releases


More Releases for Atrial

Rising Cardiovascular Disease Rates Drive Growth In Atrial Flutter: A Key Driver …
The Atrial Flutter Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Atrial Flutter Market Size and Its Estimated Growth Rate? In recent times, the market size for atrial flutter has seen swift growth. The market evaluation is expected to rise from $19.92
Elevated Prevalence Of Atrial Fibrillation Fuels Growth In The Left Atrial Appen …
What Are the Projected Growth and Market Size Trends for the Left Atrial Appendage Closure Device Market? The left atrial appendage closure device market will grow from $1.67 billion in 2024 to $2 billion in 2025, at a CAGR of 19.5%. The growth is attributed to the rising prevalence of atrial fibrillation, advancements in stroke prevention strategies, clinical evidence and research, minimally invasive alternatives, and a preference for non-pharmacological options. The left
Atrial Fibrillation Surgery Devices Market - Restoring Rhythm, Transforming Live …
Newark, New Castle, USA: The "Atrial Fibrillation Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Atrial Fibrillation Surgery Devices Market: https://www.growthplusreports.com/report/atrial-fibrillation-surgery-devices-market/8777 This latest report researches the
Atrial Fibrillation Market - Unveiling the Path to a Steady Heart: Advancements …
Newark, New Castle, USA - new report, titled Atrial Fibrillation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Atrial Fibrillation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Atrial Fibrillation market. The report offers an overview of the market, which
Atrial Fibrillation Market Insights, Forecast to 2030
The report extensively examines the global Atrial Fibrillation market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Atrial Fibrillation . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to